News

Following closely on the publication of the PregInPoxVac children’s protocol, the PregInPoxVac maternal protocol paper has now been published in BMJ Open.

New results from the D3 (PENTA-21) trial, sponsored by Fondazione Penta ETS, add to the evidence that dolutegravir-based treatment remains a strong option for children living with HIV,

Every year, millions of children are admitted to hospitals with severe pneumonia, mostly in resource-limited settings. Until now, standard international guidelines have required children to stay in the hospital for…

Fondazione Penta ETS and the Medicines Patent Pool (MPP) have signed a Memorandum of Understanding (MoU), formalising a strategic collaboration to support the development and equitable access of priority health…

A protocol paper describing part of the PregInPoxVac study has been published in Vaccine. The paper outlines the design of a phase 3 trial evaluating the safety and immunogenicity of…

We’re pleased to share that a large delegation of Penta experts is heading to Rio de Janeiro, Brazil at the end of the month, taking part in three major events…

Uganda continues to face a high HIV burden among children and adolescents, with an estimated 71,000 young people aged under 15 years living with HIV and 3,100 AIDS-related deaths in…

Fondazione Penta is pleased to be part of a new international clinical development programme led by Enanta Pharmaceuticals, a clinical-stage biotechnology company, to advance zelicapavir, a new oral antiviral in…

About the author My name is José Sumbana, a young African investigator and Postdoctoral Fellow with a background in Microbiology, Biotechnology, and Life Sciences.

Every winter, hospitals around the world fill with infants struggling to breathe because of respiratory syncytial virus (RSV). Estimates show that RSV infects nearly every child by the time they…

Geneva, 24 June 2026 – An innovative international clinical trial to evaluate life-saving antibiotic combinations for newborns with sepsis has expanded to India, one of several Asian countries participating in…

We are pleased to share that Penta’s 2025 Annual Report is now available on our website. For more than thirty years, Penta has worked to ensure that pregnant people,

This article was written by Penta Young Reporter, Arlene. Find out more about the Penta Young Reporters here. What is CHIVA?

This article was originally published in the UCL Innovative Clinical Trials Unit website. Penta contributed to BREATHER+ by coordinating youth involvement through its Youth Trial Boards.

Funded by Global Health EDCTP3 and the European Union, the project brings together 21 partners across Africa, Europe and the United States to improve early HIV treatment outcomes in infants.

When we think of Tuberculosis (TB), we often picture an adult with a persistent cough. But there is another side that is often left in the shadows, the children who…

Involving young people in clinical research might feel like a leap into the unknown for many researchers, but Penta’s experience shows that it is one of the most rewarding ways…

Women in STEM : the future catalysts for change STEM is ever changing. It is vast, innovative, and transformative. It pioneers the very way in which people live,